It’s been a long time coming, but well worth the wait. Ribapharm Inc., having filed for its initial public offering in June 2000, got the deal done Friday, pricing 26 million shares at $10 apiece, raising $260 million and entering biotechnology’s IPO record book. (BioWorld Today)
